UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dissecting the activation of thienopyridines by cytochromes P450 using a pharmacodynamic assay in vitro

The Journal of pharmacology and experimental therapeutics, 2011-11, Vol.339 (2), p.589-596

2011

Volltextzugriff (PDF)

Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats

European journal of pharmacology, 2007-09, Vol.570 (1), p.167-174

2007

Volltextzugriff (PDF)

Design, Structure−Activity Relationships, X-ray Crystal Structure, and Energetic Contributions of a Critical P1 Pharmacophore: 3-Chloroindole-7-yl-Based Factor Xa Inhibitors

Journal of medicinal chemistry, 2008-12, Vol.51 (23), p.7541-7551

2008

Volltextzugriff (PDF)

Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors

Bioorganic & medicinal chemistry letters, 2011-12, Vol.21 (24), p.7516-7521

2011

Volltextzugriff (PDF)

Aroylguanidine-based factor Xa inhibitors: The discovery of BMS-344577

Bioorganic & medicinal chemistry letters, 2009-12, Vol.19 (24), p.6882-6889

2009

Volltextzugriff (PDF)

Synthesis and evaluation of acylguanidine FXa inhibitors

Bioorganic & medicinal chemistry, 2008-08, Vol.18 (16), p.4696-4699

2008

Volltextzugriff (PDF)

Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (15), p.4034-4041

2009

Volltextzugriff (PDF)

Development and validation of a platelet calcium flux assay using a fluorescent imaging plate reader

Analytical biochemistry, 2006-10, Vol.357 (2), p.216-224

2006

Volltextzugriff (PDF)

Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitors

Bioorganic & medicinal chemistry letters, 2007-11, Vol.17 (21), p.5952-5958

2007

Volltextzugriff (PDF)

The Discovery of Sulfonamide Endothelin Antagonists and the Development of the Orally Active ETA Antagonist 5-(Dimethylamino)-N-(3,4-dimethyl-5- isoxazolyl)-1-naphthalenesulfonamide

Journal of medicinal chemistry, 1994-02, Vol.37 (3), p.329-331

1994

Volltextzugriff (PDF)

Biphenylsulfonamide Endothelin Receptor Antagonists. Part 3: Structure–Activity Relationship of 4′-Heterocyclic Biphenylsulfonamides

Bioorganic & medicinal chemistry letters, 2002-02, Vol.12 (4), p.517-520

2002

Volltextzugriff (PDF)

Discovery and Structure-Activity Relationships of Sulfonamide ETA-Selective Antagonists

Journal of medicinal chemistry, 1995-04, Vol.38 (8), p.1344-1354

1995

Volltextzugriff (PDF)

Ketene aminal-based lactam derivatives as a novel class of orally active FXa inhibitors

Bioorganic & medicinal chemistry letters, 2005-12, Vol.15 (24), p.5453-5458

2005

Volltextzugriff (PDF)

Biphenylsulfonamide Endothelin Receptor Antagonists. 2. Discovery of 4‘-Oxazolyl Biphenylsulfonamides as a New Class of Potent, Highly Selective ETA Antagonists

Journal of medicinal chemistry, 2000-08, Vol.43 (16), p.3111-3117

2000

Volltextzugriff (PDF)

Mutational Analysis of the Endothelin Type A Receptor (ETA): Interactions and Model of the Selective ETA Antagonist BMS-182874 with the Putative ETA Receptor Binding Cavity

Biochemistry (Easton), 1996-02, Vol.35 (8), p.2548-2556

1996

Volltextzugriff (PDF)

Binding of 125I-Endothelin-1 and 125I-Endothelin-3 in Rabbit Saphenous Vein: Evidence for an Atypical ET Binding Component

Journal of cardiovascular pharmacology, 1993, Vol.22 Suppl 8 (Supplement 8), p.S132-S135

1993

Volltextzugriff (PDF)

Erratum to “Ketene aminal-based lactam derivatives as a novel class of orally active FXa inhibitors” [Bioorg. Med. Chem. Lett. 15 (2005) 5453–5458]

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (5), p.1449-1449

2006

Volltextzugriff (PDF)

Site-specific biotinylation

International Journal of Peptide and Protein Research, 1992-12, Vol.40 (6), p.567-574

1992

Volltextzugriff (PDF)

Site-specific biotinylation : a novel approach and its application to endothelin-1 analogs and PTH-analog

International journal of peptide and protein research, 1992-12, Vol.40 (6), p.567-574

1992

Volltextzugriff (PDF)

The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta

Biochemical and biophysical research communications, 1992-06, Vol.185 (3), p.887-892

1992

Volltextzugriff (PDF)

Molecular characterization of angiotensin II type II receptors in rat pheochromocytoma cells

Peptides (New York, N.Y. : 1980), 1992-05, Vol.13 (3), p.499-508

1992

Volltextzugriff (PDF)

Vascular A10 cell membranes contain an endothelin metabolizing neutral endopeptidase

Biochemical and biophysical research communications, 1991-04, Vol.176 (1), p.423-430

1991

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(97)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(65)
Animals
(37)
Humans
(37)
Male
(29)
Biological And Medical Sciences
(27)
Pharmacology & Pharmacy
(24)
Rats
(20)
Medical Sciences
(19)
Chemistry, Medicinal
(17)
Pharmacology. Drug Treatments
(15)
Physical Sciences
(14)
Biochemistry & Molecular Biology
(13)
Chemistry
(13)
Female
(12)
Structure-Activity Relationship
(12)
Rats, Sprague-Dawley
(11)
Chemistry, Organic
(10)
Fundamental And Applied Biological Sciences. Psychology
(10)
Molecular Sequence Data
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Dissecting the activation of thienopyridines by cytochromes P450 using a pharmacodynamic assay in vitro

Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats

Design, Structure−Activity Relationships, X-ray Crystal Structure, and Energetic Contributions of a Critical P1 Pharmacophore: 3-Chloroindole-7-yl-Based Factor Xa Inhibitors

Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors

Aroylguanidine-based factor Xa inhibitors: The discovery of BMS-344577

Synthesis and evaluation of acylguanidine FXa inhibitors

Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors

Development and validation of a platelet calcium flux assay using a fluorescent imaging plate reader

Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitors

The Discovery of Sulfonamide Endothelin Antagonists and the Development of the Orally Active ETA Antagonist 5-(Dimethylamino)-N-(3,4-dimethyl-5- isoxazolyl)-1-naphthalenesulfonamide

Biphenylsulfonamide Endothelin Receptor Antagonists. Part 3: Structure–Activity Relationship of 4′-Heterocyclic Biphenylsulfonamides

Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of N-[[2‘-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1‘-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), A Highly Potent and Orally Active ETA Selective Antagonist

Discovery and Structure-Activity Relationships of Sulfonamide ETA-Selective Antagonists

Ketene aminal-based lactam derivatives as a novel class of orally active FXa inhibitors

Biphenylsulfonamide Endothelin Receptor Antagonists. 2. Discovery of 4‘-Oxazolyl Biphenylsulfonamides as a New Class of Potent, Highly Selective ETA Antagonists

Biphenylsulfonamide Endothelin Antagonists: Structure−Activity Relationships of a Series of Mono- and Disubstituted Analogues and Pharmacology of the Orally Active Endothelin Antagonist 2‘-Amino-N- (3,4-dimethyl-5-isoxazolyl)-4‘-(2-methylpropyl)[1,1‘-biphenyl]-2-sulfonamide (BMS-187308)

Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonist

Mutational Analysis of the Endothelin Type A Receptor (ETA): Interactions and Model of the Selective ETA Antagonist BMS-182874 with the Putative ETA Receptor Binding Cavity

Binding of 125I-Endothelin-1 and 125I-Endothelin-3 in Rabbit Saphenous Vein: Evidence for an Atypical ET Binding Component

Erratum to “Ketene aminal-based lactam derivatives as a novel class of orally active FXa inhibitors” [Bioorg. Med. Chem. Lett. 15 (2005) 5453–5458]

Site-specific biotinylation

Site-specific biotinylation : a novel approach and its application to endothelin-1 analogs and PTH-analog

The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta

Molecular characterization of angiotensin II type II receptors in rat pheochromocytoma cells

Vascular A10 cell membranes contain an endothelin metabolizing neutral endopeptidase

Suchergebnisse filtern